Related Experiment Video
Updated: Jun 27, 2026
13:33
Infinium Assay for Large-scale SNP Genotyping Applications
Published on: November 19, 2013
A comprehensive evaluation of SNP genotype imputation
Michael Nothnagel1, David Ellinghaus, Stefan Schreiber
1Institute of Medical Informatics and Statistics, Christian-Albrechts University, Kiel, Germany.
Human Genetics
|December 18, 2008
Summary
Genotype imputation methods like BEAGLE and MACH accurately predict individual genetic data for complex disease studies. These tools offer reliable performance, with BEAGLE and MACH being recommended for user-friendliness and efficiency.
Area of Science:
- Genetics
- Bioinformatics
- Computational Biology
Background:
- Genome-wide association studies (GWAS) are crucial for understanding complex diseases.
- Genotype imputation enhances GWAS power by predicting genotypes at untyped loci using reference panels like HapMap.
- A comprehensive comparison of imputation methods using consistent genome-wide SNP data is lacking.
Purpose of the Study:
- To evaluate and compare the performance of four publicly available genotype imputation programs: BEAGLE, IMPUTE, MACH, and PLINK.
- To assess imputation accuracy and efficacy across different genome-wide SNP datasets in a single population.
Main Methods:
- Utilized genome-wide SNP data from 449 German individuals.
- Genotyped individuals using Affymetrix 5.0 (500k), Affymetrix 6.0 (1,000k), and Illumina 550k SNP sets.
- Compared BEAGLE, IMPUTE, MACH, and PLINK for genotype imputation accuracy and imputation efficacy.
Main Results:
- HapMap-based imputation is powerful and reliable in a northern European population, even in complex regions like the MHC.
- All four programs demonstrated high accuracy in genotype predictions.
- Significant variation in imputation efficacy (number of SNPs imputed) was observed among the programs.
- BEAGLE, IMPUTE, and MACH showed similar accuracy-efficacy trade-offs, outperforming PLINK.
Conclusions:
- Genotype imputation using HapMap data is effective for genetic studies in European populations.
- BEAGLE and MACH are recommended for practical application due to their superior user-friendliness and lower memory requirements compared to IMPUTE.
- PLINK demonstrated poorer overall performance in this comparative analysis.
Related Concept Videos
01:05Single Nucleotide Polymorphisms-SNPs
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
02:26Comparing Copy Number Variations and SNPs
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
01:11Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...